BIOTECH: CANCER DRUG FAILED TO EXTEND PATIENT LIVES After Missing Mark in Clinical Trials, Halozyme Focuses on Delivery Platform By Jared Whitlock Sunday, November 10, 2019 Tweet Phillip Britanabe, senior research associate at Halozyme, works in the company’s lab. Photo by Jamie Scott Lytle. For many biotechs, the news would be a death knell...